Title

Pharmacy Practice Residency Programs

Meta
Meta description
Memphis Pharmacy Practice Residency Programs
Content
Page introduction
The Memphis VA Medical Center, located at 1030 Jefferson Ave in Memphis Tennessee, capital of blues and barbeque, is part of the VISN 9 VA Healthcare Network. It is a 250-bed facility with an additional 60-bed Spinal Cord Injury Unit, numerous specialty clinics, with primary care services located at the main facility and nine community-based outpatient clinics. The facility is accredited by the Joint Commission and is classified as a complex, Level I Facility.
Generate a table of contents from major headings
No table contents
Main content
Memphis VAMC Entrance

The Memphis VA Medical Center is a teaching hospital, providing a full range of patient care services, state-of-the-art technology and many educational and research opportunities. Comprehensive health care is provided through primary, secondary, and tertiary care, in areas of medicine, surgery, psychiatry, physical medicine and rehabilitation, spinal cord injury, neurology, oncology, dentistry, and geriatrics. Specialized outpatient services are provided through general, specialty, and subspecialty outpatient clinics including a women's health center. Services are available to more than 196,000 veterans living in a 53-county tristate area (Tennessee, Arkansas, and Mississippi).

The Memphis VA Medical Center long-standing tradition of providing clinical pharmacy services to the medical center and training highly qualified pharmacy residents. The program was first accredited in 1963 and over 260 residents have completed training. Pharmacy residency training programs at the Memphis VA Medical Center have allowed residents to train at an advanced level of practice in a progressive pharmacy environment. Clinical pharmacy specialists contribute to clinical services throughout the medical center and provide a wide variety of clinical pharmacy experiences including medical ICU, surgical ICU, cardiology ICU, nutrition support, internal medicine, geriatrics, palliative care, spinal cord injury, hematology/oncology, emergency medicine, practice management, pharmacoeconomics, psychiatry, primary care and home based primary care. Longitudinal clinic experiences include hypertension, hyperlipidemia, pain management, heart failure, emergency medicine, neurology, rheumatology, hematology/oncology, polypharmacy/transitions of care, geriatrics, HIV, and Hepatitis C.

Pharmacy residents are provided the opportunity to accelerate their growth beyond entry-level professional competence in patient-centered care, pharmacy operational services, and leadership skills that can be applied in any position and in any practice setting.  Residents acquire substantial knowledge required for skillful problem solving, refine their problem-solving strategies, strengthen their professional values and attitudes, and advance the growth of their clinical judgment.  The instructional emphasis is on the progressive development of clinical judgment, a process begun in the advanced pharmacy practice experiences (APPE or clerkships) of the professional school years but requiring further extensive practice, self-reflection, and shaping of decision-making skills fostered by feedback on performance.  The residency year provides a productive environment for accelerating growth beyond entry-level professional competence through supervised practice under the guidance of model practitioners.  Specifically, residents will acquire these skills and competencies: managing and improving the medication-use process; providing evidence-based, patient-centered medication therapy management with interdisciplinary teams; exercising leadership and practice management; demonstrating project management skills; providing medication and practice-related education/training; and utilizing medical informatics.

The VAMC Memphis offers three ASHP accredited residency programs, a PGY1 Pharmacy Practice Residency as well as two PGY-2 programs, one in Internal Medicine and one in Ambulatory Care.

VAMC Memphis Welcomes our 2022-2023 PGY1 and PGY2 Pharmacy Residents

2022-2023 Pharmacy Residents

Left to right: Angela Wuerger, Courtney Butterfass, Jillian Morgan, Ally Ponder, Jeremiah Wojtowicz, Caroline Williams, Lauren Jackson, Walesha Yates, Sreemathi Palanisamy

PGY1 Program

PGY1 Program Description

The VAMC Memphis has been training Pharmacy Practice residents since 1963. The PGY-1 residency is a 12-month post-Doctor of Pharmacy training program accredited by ASHP. The goals of this residency are to enable pharmacists to develop the knowledge and experience necessary to provide pharmaceutical care to both ambulatory and hospitalized patients with a strong emphasis on developing clinical skills. The opportunity for residents to participate in innovative practice areas is a direct result of VAMC Memphis’ long history of clinical pharmacy involvement and the unique practice environment that is found in a federal healthcare facility. Upon completion of the PGY-1 program, the resident will be eligible for board certification and a PGY-2 pharmacy residency training program.

Full-time clinical services are provided by clinical pharmacy specialists in the following areas in which residents can train, working with experienced pharmacist practitioners:

  • Ambulatory Care
  • Geriatrics
  • Internal Medicine
  • Infectious Disease/Antimicrobial Stewardship
  • Inpatient Mental Health
  • Outpatient Mental Health
  • Neurology
  • Nutritional Support
  • Medical Intensive Care
  • Surgery Intensive Care
  • Cardiology 
  • Rheumatology
  • Spinal Cord Injury
  • Palliative Care
  • Home Based Primary Card
  • Emergency Department
  • Hematology/Oncology

Residents have ongoing ambulatory clinic involvement in three or more practice areas. Residents work closely with the Pharmacy Director to develop practice management skills with emphasis on all aspects of clinical pharmacy services. Training schedules include flexibility to allow residents to pursue areas of personal interest. Research and scholarly activities are an important aspect of the VAMC Memphis Residency program, and the residents will complete projects that will improve patient care. Instructional and educational opportunities are available for residents to develop teaching skills by presenting lectures and small group discussions.

Program Purpose

The purpose of the Memphis Veterans Affairs Medical Center PGY1 Pharmacy Residency Program is to build on the Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions and to prepare graduate pharmacists for the practice of pharmacy as exemplified by the concepts of pharmaceutical care. The pharmacist completing the residency training program will independently and confidently manage patient disease states and drug therapy focused on achieving appropriate patient outcomes.  The pharmacist will be a proficient member of the healthcare team, proactively manage practice issues, possess marketable practice skills, and exhibit effective teaching and communication skills. The pharmacist will commit to continuous lifelong learning and the advancement of the pharmacy profession. Upon completion of the PGY1 program, the resident will be eligible for board certification and a postgraduate year two (PGY2) pharmacy residency training program.

Program Structure

Required Rotations (4 weeks each)

  • Ambulatory Care
  • Critical Care (MICU/SICU/Nutrition)
  • Geriatrics
  • Internal Medicine
  • Practice Management/Drug Information/Pharmacoeconomics

Elective Rotations

  • Repeat of core rotation(s)
  • Cardiology
  • Outpatient Mental Health
  • Inpatient Mental Health
  • Spinal Cord Injury
  • Home Based Primary Care
  • Palliative Care/Pain Management
  • Outpatient Pain Management
  • Hematology/Oncology
  • Antimicrobial Stewardship/ID

Longitudinal Ambulatory Care Experiences (2 months each, resident chooses three)

  • Pain Management
  • Pain Coping Group
  • Rheumatology 
  • Lipid Clinic 
  • ID/HIV  
  • GI/Hepatitis C

Other longitudinal learning experiences

  • Orientation to all aspects of the health system’s pharmacy services, residency and PharmAcademic
  • ACLS/BLS Certification
  • Adverse Drug Reaction Monitoring
  • Formulary Management
  • Antibiotic Surveillance
  • Applied Pharmacokinetics
  • Patient Education
  • Pharmaceuticals preparation and dispensing, applied pharmacy practice
  • On a rotating basis, each resident serves as Chief Resident concurrent with other rotations

Other required activities

  • Pharmacotherapy Presentations/CE program
  • Newsletter article
  • Medication Usage Evaluation
  • Journal Club
  • IRB approved research project 
  • University of Tennessee College of Pharmacy Teaching Learning Program 
  • Clinical/Operational Staffing on a rotational basis

Benefits

  • Two and one-half weeks paid vacation and sick leave plus federal holidays 
  • Participation in VA Plans/Programs (i.e. health insurance)
  • Three days paid interview leave and paid leave to attend and participate in state and national pharmacy meetings

Application Process

Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy

The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.
PhORCAS application requirements:  

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

Summary

Type/Duration: PGY1 Pharmacy Residency/12 months 
Number of Positions: 5
Application Deadline: December 31, 2022
Estimated Stipend: $47,397    
Interview Required: Yes 
ASHP Program Code: 54200
NMS Match Code: 190213

Contact Information

For more information about the PGY1 Pharmacy Residency Program, please contact:

Joshua Sullivan, PharmD, BCACP, BCPS, BCGP
Associate Chief, Clinical Pharmacy Programs
PGY1 Pharmacy Residency Program Director
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN

Phone: 901-577-7100

Email: josh.sullivan@va.gov

PGY2 Ambulatory Care Program Description

The VAMC Memphis Post Graduate Year Two Ambulatory Care Pharmacy Residency is a 12-month training program accredited by the American Society of Health-System Pharmacists. This program is a post-Doctor of Pharmacy program to be completed after an ASHP accredited PGY1 residency. The goal of this residency is to enable pharmacists to develop the knowledge and experience necessary to provide pharmaceutical care to ambulatory patients with a strong emphasis on developing and mastering clinical skills in the outpatient setting. The resident will function independently and collaboratively with team members to achieve optimal drug therapy outcomes. The resident will be responsible for pharmacotherapy decisions, patient counseling, writing progress notes and monitoring drug therapy. The resident will also create and implement a clinical service, participate in several educational programs and will have the opportunity for didactic teaching and precepting students to develop teaching skills. Residents work closely with the Pharmacy Director and Residency Program Director to develop practice management skills with emphasis on all aspects of clinical pharmacy services. Through a partnership with the University of Tennessee College of Pharmacy, residents will participate in a teaching and learning program. Experienced clinical pharmacy specialists provide clinical services in the following areas: Primary Care, Home Based Primary Care, Geriatrics, Neurology, Cardiology, Rheumatology, Emergency Room, Memory Clinic, Pain Management, Hematology/Oncology, HIV and Hepatitis C. Residents have the opportunity to train in all of these sites. Training schedules include flexibility to allow residents to pursue areas of personal interest. Research and scholarly activities are an important aspect of the VAMC Memphis Residency program, and residents participate in projects that will improve patient care. As part of the nation's health care system, the Memphis VA also interacts with other VA pharmacy programs for a continuous sharing of innovative approaches to improve patient drug therapy outcomes.

Program Purpose

The purpose of the VAMC Memphis PGY2 Ambulatory Care Pharmacy Residency Program is to build on the Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency program to contribute to the development of clinical pharmacists in Ambulatory Care. Residents will have opportunities to function independently as practitioners and work collaboratively as members of the healthcare team by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that optimizes medication therapy. The PGY2 Ambulatory Care resident will exercise proficiency in communication and education of other health care professionals, patients and the community. Upon completion of the PGY2 Ambulatory Care residency, the resident will be prepared to establish collaborative interdisciplinary ambulatory care practices, possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in Ambulatory Care (BCACP).

Program Structure

Required Rotations:  

  • Pharmacotherapy Clinic I (PCI)
  • Pharmacotherapy Clinic II (PCII)
  • Pharmacotherapy Clinic III (PCIII)
  • Home Based Primary Care (HBPC)/Anticoagulation
  • Outpatient pain management
  • Outpatient Mental Health
  • Practice Management

Elective rotations (4 weeks each):

  • Cardiology
  • Geriatrics (long-term care)
  • Hematology/Oncology
  • ID/Hepatitis C
  • Infectious Disease/Antimicrobial Stewardship
  • Internal Medicine/Transitional Care
  • Palliative Care/Pain Management

Required, year-long, continuous experiences 

  • Adverse Drug Reaction Monitoring
  • Practice Management/Formulary Management
  • Patient Education
  • Project Management/Research
  • Resident Pharmacotherapy Clinic
  • Teaching/Precepting

Elective pharmacotherapy longitudinal experiences. Residents will choose from the following to participate in during pharmacotherapy clinics and other elective months: 

  • Rheumatology Clinic 
  • Hypertension Clinic
  • Lipid Clinic
  • Heart Failure Clinic
  • Endocrinology Clinic
  • GI/Hepatitis Clinic
  • Nephrology Clinic

Other required activities: 

  • Pharmacotherapy Presentations
  • Newsletter article
  • Journal Club
  • IRB approved research project 
  • University of Tennessee College of Pharmacy Teaching Learning Program 
  • Ambulatory Care Staff Meeting Presentations
  • Outpatient pharmacy operational/transitions of care staffing on a rotational basis

Benefits

  • Two and one-half weeks paid vacation and sick leave plus federal holidays
  • Participation in VA Plans/Programs (health insurance, etc.)
  • Three days paid interview leave
  • Paid leave to attend and participate in state and national pharmacy meetings

Application Process

Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist

The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.
PhORCAS application requirements:  

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

Summary

Type/Duration: PGY2 Ambulatory Care Residency/12 months
Number of Positions: 2
Application Deadline: January 6, 2023
Estimated Stipend: $50,679 
Interview Required: Yes (with formal presentation)
ASHP Program Code: 54053
NMS Match Code: 735465

Contact Information

For more information about the PGY2 Ambulatory Care Residency Program, please contact:

Katelyn M. Wassell, PharmD, BCACP
Clinical Pharmacy Practitioner – Ambulatory Care
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN

Phone: 901-523-8990 x6927

Email: Katelyn.wassell@va.gov

PGY2 Internal Medicine Program

Introduction

The VAMC Memphis PGY2 Pharmacy Residency in Internal Medicine is a 12-month training program that aims to train highly motivated and qualified pharmacists to provide exceptional care for adult internal medicine patients. The practice setting is a 250-bed tertiary VA hospital in Memphis, TN. The pharmacy resident will work as an integral member of the healthcare team, along with medical residents and fellows affiliated with the University of Tennessee Health Science Center. The resident will have the opportunity to develop practice management skills, participate in educational programs, provide formal lectures, and precept pharmacy students. The resident will also participate in projects designed to improve patient care and outcomes. Flexible training schedules allow the resident to pursue areas of personal interest while meeting the educational goals of the program. Appointment is within the Federal government, and residents are therefore subject to all regulations and requirements of the Federal system.

Purpose

The purpose of the PGY2 Internal Medicine Program is to build upon the resident’s Doctor of Pharmacy education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in Internal Medicine. The PGY2 Internal Medicine residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 Internal Medicine pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Learning Experiences  

Core rotations:

  • Orientation (if PGY1 not completed at Memphis VAMC)
  • Internal Medicine I (8 weeks)
  • Internal Medicine II (8 week)
  • Ambulatory Care (1 month)
  • Cardiology (1 month)
  • Critical Care (1 month)
  • Geriatric Medicine (1 month)

Elective rotations:

  • Repeat of any required rotation
  • Infectious Disease/Antimicrobial Stewardship
  • Inpatient Mental Health 
  • Nutrition Support
  • Palliative Care/Pain Management

Additional requirements: 

  • Practice Management Longitudinal
    • Chief Resident (on a rotating basis with other residents)
    • Participation in formulary management/PADRs
    • Quality improvement project/protocol and/or order set development
  • IRB-approved research project (including written manuscript and presentation at MidSouth Pharmacy Residents Conference)
  • Pharmacotherapy CE presentations (2)
  • Journal club presentations (2)
  • Local or regional presentation/poster/abstract or case report 
  • Teaching Certificate Program (optional, if not completed PGY1 year)
  • Weekend clinical, TOC and operation inpatient staffing
  • Participation in Resident-Preceptor Mentor program

Benefits

  • Two and one-half weeks paid vacation and sick leave plus federal holidays 
  • Participation in VA Plans/Programs (health insurance, etc.)
  • Three days paid interview leave 
  • Paid leave to attend and participate in state and national pharmacy meetings

Application Process

Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist

The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.

PhORCAS application requirements:  

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

Summary

Type/Duration: PGY2 IM Residency/12 months 
Number of Positions: 1-2
Application Deadline: January 6, 2023
Estimated Stipend: $50,679    
Interview Required: Yes (with formal presentation)
ASHP Code: 54035
NMS Match Code: 701056

Contact Information

For more information about the PGY2 Internal Medicine Residency Program, please contact:

Tenley E. Ryan, PharmD, BCPS
Clinical Pharmacy Specialist – Internal Medicine/Transitions of Care
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN

Phone: (901) 523-8990 x6720
Email: tenley.ryan@va.gov

Pharmacy Residency Application

Application Process The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.

All of your application documents will need to uploaded to PhORCAS. For more information: www.ashp.org/phorcas.

PhORCAS application requirements for all programs: 

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

PGY1 Application Requirements

  • Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy
  • Application due: December 31
  • ASHP Program Code: 54200
  • NMS Match Code: 190213

PGY2 Internal Medicine Application Requirements

  • Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist
  • Application due: January 4 
  • ASHP Program Code: 54035
  • NMS Match Code: 701056

PGY2 Ambulatory Care Application Requirements

  • Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist
  • Application due: December 31
  • ASHP Program Code: 54053
  • NMS Match Code: 735465
Current Pharmacy Residents

We are pleased to welcome our new 2022-2023 residency class!

PGY2 Internal Medicine Residents

  • Ally Ponder – Samford University, PGY-1 Pharmacy Residency, Memphis VAMC
  • Courtney Butterfass – Virginia Commonwealth University, PGY-1 Pharmacy Residency, Indiana University Health

PGY2 Ambulatory Care Residents

  • Jillian Morgan – Belmont University, PGY-1 Pharmacy Residency, Memphis VAMC
  • Angela Wuerger – University of Kentucky, PGY-1 Pharmacy Residency, Memphis VAMC

PGY1 Residents

  • Lauren Jackson – Samford University
  • Sreemathi Palanisamy – St. Louis College of Pharmacy
  • Caroline Williams – University of Tennessee
  • Jeremiah Wojtowicz – University of Tennessee
  • Walesha Yates – University of Tennessee

2022-2023 PGY1 and PGY2 Pharmacy Residents

Courtney Butterfass was born in Fairfax, VA. She attended high school at Clarke County High School in Berryville, VA and earned her Bachelor of Science degree from High Point University- High Point, NC. Courtney returned to Virginia to complete her pharmacy degree at the Virginia Commonwealth University School of Pharmacy. In pharmacy school, Courtney was a member of the APhA, ASHP, Student Pharmacist Policy and Advocacy Association, and Kappa Epsilon. In her spare time, Courtney enjoys spending time with friends and family, exercising, traveling, and attending concerts/sporting events. Courtney is honored and excited to be a part of the Internal Medicine PGY2 program at the Memphis VA Medical Center.

Lauren Jackson was born and raised in Birmingham, Alabama. After graduating from Oak Mountain High School, she obtained her Bachelor of Science in Pharmacy Studies from Samford University in Birmingham, Alabama. Lauren continued her education at Samford University receiving her Doctor of Pharmacy and Master of Public Health degrees. In pharmacy school, Lauren was a member of APhA-ASP, SSHP, ASHP and Rho Chi. Her pharmacy interests include ambulatory care and internal medicine. In her spare time, she enjoys the outdoors, planting, and spending time with friends and family. Lauren is excited to be a part of the Memphis VA pharmacy team.

Jillian Morgan was born in Murfreesboro, TN. She attended high school at Siegel High School in Murfreesboro, TN and completed her pharmacy school pre-requisites at Middle Tennessee State University. In pharmacy school, Jillian was an active member of APhA, TPA, ASHP, CPFI, Kappa Psi, and ACCP. Jillian completed her first year of post-graduate training at the Memphis Veteran’s Affairs Medical Center in 2022. Throughout her PGY1 year, Jillian was an active member in Federal Resident Council. In her spare time, Jillian enjoys spending time with her family and friends, traveling, attending concerts, and working out. Jillian is honored and excited to be a part of the Ambulatory Care PGY2 program at the Memphis VA Medical Center.

Sree Palanisamy was born in the southern part of India and grew up in the suburbs of Chicago, Illinois. She went to pursue a seven - year dual B.S/PharmD degree program at St. Louis College of Pharmacy. In pharmacy school, Sree was involved with the Student Pharmacy Association, SCCP, SNPhA, APhA-ASP, Indian Student Association, and International Student Organization. Through residency, Sree is looking forward to exploring her clinical interests in infectious disease, ambulatory care, and internal medicine. In her spare time, Sree enjoys hiking, traveling, cooking, and spending time with family and friends. She is grateful and excited to start a new chapter in her life by being part of the VAMC Memphis Pharmacy Residency Program.

Ally Ponder was born and raised in Jacksonville, Alabama. After graduating from Pleasant Valley High School, she obtained her Bachelor of Science in Pharmacy Studies from Samford University in Birmingham, Alabama. Remaining at Samford University, Ally completed her Master of Public Health and Doctor of Pharmacy degrees. During her time there, she was a member of APhA-ASP, SNPhA, SSHP, and Rho Chi. In her spare time, she enjoys baking, traveling, and spending time with her friends and family. Ally is excited to continue her pharmacy training as part of the Internal Medicine PGY2 program at the Memphis VA Medical Center.

Caroline Elizabeth Williams has been a Tennessee resident her entire life. Born in Jackson, TN and raised in Huntingdon, TN, she graduated from Huntingdon High School. She stayed in west Tennessee and earned her Bachelor of Science degree in biology from the University of Tennessee at Martin. Caroline then attended the University of Tennessee Health Science Center College of Pharmacy on the Memphis campus. In pharmacy school, Caroline was a member of APhA-ASP, Phi Delta Chi, Phi Lambda Sigma, and Rho Chi. Her areas of interest in pharmacy include ambulatory care, internal medicine, and cardiology. Caroline recently eloped and married her college sweetheart at the Grand Canyon in Arizona. In her spare time, Caroline enjoys being an aunt to her 6-year-old niece, Jemma, baking and decorating cakes, and playing with her cocker spaniel, Calvin. Caroline is looking forward to starting her career as a pharmacist and is honored to be a pharmacy resident at the Memphis VA Medical Center.

Jeremiah Jordan Wojtowicz was born in Knoxville, TN. He attended Karns High School in Knoxville and graduated with a Bachelor of Science from East Tennessee State University in Johnson City, TN. Jeremiah later attended the University of Tennessee Health Science Center in Memphis for one year and Knoxville for three years. In pharmacy school, Jeremiah was an active member of Phi Delta Chi, SNPhA, and APhA-ASP. His varied pharmacy interests include behavioral health, ambulatory care, and internal medicine. In his spare time, Jeremiah enjoys going to trivia, collecting DVDs, and cheering for the Chicago Cubs and Tennessee Athletics. Jeremiah is honored to be part of the VAMC residency program and ecstatic to begin his career as a pharmacist.

Angela Wuerger was born in the Northwest suburbs of Chicago in Algonquin, IL. She attended the University of Kentucky for three years of undergraduate coursework before enrolling in pharmacy school at the University of Kentucky College of Pharmacy. She was a dual-degree pharmacy student and received her Master of Public Health in health behavior and society along with her PharmD. While she was in pharmacy school, she was a member of the Rho Chi Honor Society, Kentucky Association of Student Pharmacists, and Create Your Positive club. She completed her PGY1 pharmacy residency at the Memphis VA Medical Center. When she is off duty, Angela enjoys traveling, tending to her growing plant collection, and watching movies. She is very excited to continue to serve Veterans as a PGY2 Ambulatory Care resident at the Memphis VA!

Walesha Yates was born in Memphis, TN, but grew up in Olive Branch, MS. After graduating from Olive Branch High School, she attended The University of Mississippi and earned her B.G.S. in Biology, Chemistry, and Psychology. Walesha returned to Memphis to complete the University of Tennessee’s pharmacy school program. There, she simultaneously earned her Master of Business Administration degree from the University of Memphis and was an active member of SNPhA. Her pharmacy interests are ambulatory care, infectious disease, and emergency medicine. In her spare time, Walesha loves to perfect her photography craft, exercise, and spend time with family and friends. She is excited to begin her pharmacy career and serve the veterans at the Memphis VA.

Clinical Pharmacy Staff

Jarred Bowden, Pharm.D., BCIDP, AAHIVP
Clinical Pharmacy Practitioner, Infectious Disease/Antimicrobial Stewardship, Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, Universiry of Florida Health Shands Hospital
PGY-2 Pharmacy Residency in Infectious Disease,Universiry of Florida Health Shands Hospital

Emily Brandl, Pharm.D., BCGP
Clinical Pharmacy Practitioner, Pain Management and Palliative Care
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Dana Brown, Pharm.D.
Clinical Pharmacy Practitioner, Ambulatory Care - Anticoagulation
EDUCATION:      Pharm.D., Xavier University College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN  

Stephanie Coveart, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Outpatient Mental Health; Assistant Professor, University of Tennessee College of Pharmacy   
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, Tennessee Valley Healthcare System, Nashville, TN
PGY-2 Pharmacy Residency in Psychiatry, Tennessee Valley Healthcare System, Nashville, TN

Cary Duncan, Pharm.D., BCPS
Associate Chief, Operations; Clinical Pharmacy Practitioner, Ambulatory Care
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Sidney D’Amico, Pharm.D.
Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care
EDUCATION:      Pharm.D., University of Mississippi School of Pharmacy
PGY-1 Pharmacy Residency, Baptist Memorial Hospital, Memphis, TN
PGY-2 PharmacyResidency in Internal Medicine, Barnes-Jewish Hospital, St. Louis, MO

Kevin Freeman, Pharm.D., BCNSP
Chief, Pharmacy Service; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Katie Frieling, Pharm.D., BCACP
Clinical Pharmacy Practitioner, Ambulatory Care 
EDUCATION:      Pharm.D., Union University School of Pharmacy 
PGY-1 Pharmacy Residency, Ochsner Medical Center, New Orleans, LA
PGY-2 Ambulatory Care, University at Buffalo-Buffalo Medical Group, Buffalo, NY

Amanda R. Gillion, Pharm.D., BCPS 
Clinical Pharmacy Practitioner, Medical ICU; Assistant Professor, University of Tennessee College of Pharmacy 
EDUCATION/:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency & PGY-2 Pharmacy Residency in Critical Care, Methodist University Hospital, Memphis, TN

Tommie Jo Guidry, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Spinal Cord Injury; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency & PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN

William Gust, Pharm.D.
Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care
EDUCATION:      Pharm.D., University of Mississippi School of Pharmacy
PGY-1 Pharmacy Residency, G.V. (Sonny) Montgomery VAMC, Jackson, MS
PGY-2 Pharmacy Residency in Ambulatory Care, University of Mississippi School of Pharmacy

Jonathan M. Hoover, Pharm.D., BCPS, BCGP
Clinical Pharmacy Practitioner, Internal Medicine; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN 

Amanda Howard-Thompson, Pharm.D., BCPS, CDE
Clinical Pharmacy Practitioner, Ambulatory Care and Women’s Clinic; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, LeBonheur Children’s Medical Center, Memphis, TN
PGY-2 Pharmacy Residency in Internal Medicine, Methodist University Hospital, Memphis, TN

Molly Hunt, Pharm.D.
Clinical Pharmacy Practitioner, Medicine/Surgery
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, University of Tennessee Medical Center, Knoxville, TN  
PGY-2 Pharmacy Residency in Critical Care, University of Tennessee Medical Center, Knoxville, TN  

Bryan Paul Jett, Pharm.D., BCPS, CGP
Clinical Pharmacy Practitioner, Ambulatory Care
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Angela Jolly, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Home-Based Primary Care;
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Seth Keller, Pharm.D., BCPS, CGP
Clinical Pharmacy Practitioner, Emergency Department 
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN 

Leigh Anne Keough, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Ambulatory Care/Pain Management 
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN 
PGY-2 in Transplant, Methodist University Hospital, Memphis, TN

Erin Latendresse, Pharm.D.
Clinical Pharmacy Practitioner, Ambulatory Care 
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Community Pharmacy Residency, University of Mississippi, Jackson, MS
PGY-2 Pharmacy Residency in Ambulatory Care/Academia, University of Tennessee, Memphis,TN

Sara Layman, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care; Assistant Professor, University of Tennessee College of Pharmacy
Education:     Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN 
PGY-2 in Ambulatory Care, VAMC Memphis, TN

Jacob Marler, Pharm.D., BCCCP
Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care; Assistant Professor, University of Tennessee College of Pharmacy
Education:     Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, Methodist University Hospital, Memphis, TN
PGY-2 in Critical Care, Methodist University Hospital, Memphis, TN

Angela Marsella, Pharm.D., MBA
Clinical Pharmacy Practitioner, Outpatient Mental Health 
EDUCATION:      Pharm.D., McWhorter School of Pharmacy, Samford University 
PGY-1 Community Pharmacy Residency, University of Wisconsin-Madison School of Pharmacy, Two Rivers, WI
PGY-2 Pharmacy Residency in Mental Health, Tuscaloosa VA Medical Center, Tuscaloosa, AL

Joseph Merkel, Pharm.D., BCACP
Clinical Pharmacy Practitioner, Ambulatory Care 
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, Memphis VAMC, Memphis, TN
PGY-2 PharmacyResidency in Ambulatory Care, Memphis VAMC, Memphis, TN

Anna Mitchell, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Academic Detailing  
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN
PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN            

Daniel Neu, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care
Education:     Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Robert B. Parker, Pharm.D.
Clinical Pharmacy Practitioner, Cardiology; Associate Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of North Carolina 
Cardiovascular Pharmacotherapy Fellowship, University of Illinois, Chicago, IL

Jennifer Patton, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Pain Management, Pain POC/PACT Pain Champion
Education:     Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Lauren Peyton, Pharm.D., BCACP, CDE
Clinical Pharmacy Practitioner, Ambulatory Care 
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, Regional One Health, Memphis, TN

Carly Rainey, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Mental Health/RRTP/SUD
Education:     Pharm.D., University of Missouri, Kansas City School of Pharmacy
PGY-1 Pharmacy Residency, Chillicothe VAMC, Chillicothe, OH
PGY-2 Pharmacy Residency in Mental Health, Chillicothe VAMC, Chillicothe, OH

Kothanur Rajanna, Masters Pharmacy, B.S. Pharmacy
Clinical Pharmacy Practitioner, Hematology/Oncology, Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      MPharm, All India Institute of Medical Sciences 
B.S. Pharmacy, University of Tennessee College of Pharmacy   

Sloan Regen, Pharm.D., BPCS
Clinical Pharmacy Practitioner, Geriatrics; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:     Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, Michael E. DeBakey Medical Center, Houston, TX 
PGY-2 Pharmacy Residency in Geriatrics, Central Arkansas VHS, Little Rock, AR

Caroline Richmond, Pharm.D., BCPP
Clinical Pharmacy Practitioner, Inpatient Mental Health
EDUCATION:     Pharm.D., East Tennessee State University
PGY-1 Pharmacy Residency, St. Claire Regional Medical Center, Morehead, KY
PGY-2 Pharmacy Residency in Psychiatry, Lexington VA, Lexington, KY

Kelly C. Rogers, Pharm.D.
Clinical Pharmacy Practitioner, Cardiology; Associate Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, University of Virginia Health Sciences Center, Charlottesville, VA

Tenley Ryan, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN
& PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN                

Shannon Stewart, Pharm.D.
Clinical Pharmacy Practitioner, Palliative Care; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency with Geriatrics Emphasis, VAMC Memphis, TN

Brooke Sullivan, Pharm.D., BCPS
Clinical Pharmacy Practitioner, Ambulatory Care - Anticoagulation
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Joshua W. Sullivan, Pharm.D., BCPS, BCACP, BCGP
Associate Chief Clinical Programs, PGY1 Residency Program Director; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Camille Thornton, Pharm.D.
Clinical Pharmacy Practitioner, ID/HIV/GI/HepatitisC; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency with Ambulatory Care Emphasis, VAMC Memphis, TN

Nicholas B. Townsend, Pharm.D., BCACP
Clinical Pharmacy Practitioner, Ambulatory Care; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Katie VanBuskirk, Pharm.D.
Clinical Pharmacy Practitioner, Home-Based Primary Care
EDUCATION:      Pharm.D., University of Mississippi College of Pharmacy
PGY-1 Pharmacy Residency, VAMC Memphis, TN

Katie Wassell, Pharm.D., BCACP
Clinical Pharmacy Practitioner, Ambulatory Care; PGY-2  Ambulatory Care Residency Program Director; Assistant Professor, University of Tennessee College of Pharmacy
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Pharmacy Residency, Memphis VAMC, Memphis, TN
PGY-2 PharmacyResidency in Ambulatory Care, Memphis VAMC, Memphis, TN

Lindsey Wells, Pharm.D., BCCCP
Clinical Pharmacy Practitioner, Surgical ICU/Nutrition Support Service; Assistant Professor, University of Tennessee College of Pharmacy 
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy
PGY-1 Pharmacy Residency & PGY-2 Pharmacy Residency in Critical Care, 
Regional One, Memphis, TN

Jessica Wooster Thomas, Pharm.D., BCACP
Clinical Pharmacy Practitioner, Ambulatory Care/Cardiology/Women’s Health
EDUCATION:      Pharm.D., University of Tennessee College of Pharmacy 
PGY-1 Community Pharmacy Residency, Albertsons Companies and Midwestern University

Pharmacy Facts and Preceptor/Resident Accomplishments

Memphis VA Medical Center Pharmacy Residency Facts

  • The PGY1 program has been ASHP accredited since 1963 and over 260 residents have graduated from the PGY1 program.
  • The PGY2 Internal Medicine Program has been accredited since 2016
  • The PGY2 Ambulatory Care Residency Program has been accredited since 2017
  • Approximately 67% of residents in the past 5 years and almost 75% of the residents within the past ten years have become board certified post-residency. Certifications include pharmacotherapy, geriatrics, psychiatry, critical care, oncology and ambulatory care.
  • Approximately 62.5% of residents have been hired as clinical pharmacy specialists and 35% as clinical pharmacists over the past 5 years. The remaining residents are currently PGY2 residents.
  • Approximately half of the residents in the previous 5 years have completed PGY2 residencies.
  • Approximately 87% of the residents in the past 5 years are currently involved in precepting students and residents.
  • Approximately 75% of our preceptors are board certified.

List of Resident and Preceptor National Presentations, Posters, Publications, Awards, Research Projects and Medication Use Evaluations

Publications:

Rogers KC, Oliphant CO, Finks SW.  Clinical efficacy and safety of cilostazol: a critical review of the literature.  Drugs 2015;75(4):377-395. doi: 10.1007/s40265-015-0364-3

Parker RB, Hu ZY, Meibohm B, Laizure SC. Effects of alcohol on human carboxylesterase drug metabolism. Clin Pharmacokinet 2015;54:627-38.

Spivey CA, Liu X, Qiao Y, Mardekian J, Parker RB, Phatak H, Masseria C, Kachroo S, Abdulsattar Y, Wang J. Stroke associated with discontinuation of warfarin therapy for atrial fibrillation. Curr Med Res Opin. 2015;31:2021-9

Spivey CA, Qiao Y, Liu X, Mardekian J, Parker RB, Phatak H, Claflin AB, Kachroo S, Abdulsattar Y, Chakrabarti A, Wang J. Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation. J Manag Care Spec Pharm. 2015;21:596-606.

Sullivan J, Jett B, Cradick M, Zuber J. Effect of Clinical Pharmacist Intervention on A1C reduction in Veteran Patients with Type 2 Diabetes in a Rural Setting. Annals of Pharmacotherapy 2016: 50(12);1023-1027. DOI 10.1177

Shah R, Rogers KC, Matin K, Askari R, Rao SV.  An updated comprehensive meta-analysis of bivalirudin versus heparin use in primary percutaneous coronary intervention.  Am Heart J 2016;171(1):14-24. doi: 10.1016/j.ahj.2015.10.006. Epub 2015 Oct 20.

Shah R, Rogers KC, Ahmed AJ, King BJ, Rao SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on acute stent thrombosis: meta-analysis of randomized controlled trials.  JACC Cardiovasc Interv. 2016;9(13):1313-20. doi: 10.1016/j.jcin.2016.03.031. Epub 2016 Jun 15.

Rogers KC, Shelton MP, Finks SW.   Reversal agents for direct oral anticoagulants:  understanding new and upcoming options.  Cardiol Rev 2016;24: 310–315.  doi: 10.1097/CRD.0000000000000118

Shah R, Matin K, Rogers KC, Rao SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.  Catheter Cardiovasc Interv 2017 Aug 1;90(2):196-204. doi: 10.1002/ccd.26859. Epub 2016 Nov 10.

McDonough SL, Alford, EL, Finks SW, Parker RB, Chisholm-Burns MA, Phelps SJ. Student Pharmacists’ perceptions of a composite examination in their first professional year. Am J Pharm Educ 2016;80:1-8.

Chen F, Hu ZY, Parker RB, Laizure SC. Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application. Biomed Chromatogr 2017;31:1-8.

Laizure SC, Meibohm B, Nelson K, Chen F, Hu Z, Parker RB. Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjects. Br J Clin Pharmacol 2017; 83:2687-2694.

Finks SW, Rogers KC. Idarucizumab (Praxbind®):  The first reversal agent for a direct oral anticoagulant.  Am J Med 2017;130(5):e195-e197.  doi: 10.1016/j.amjmed.2016.11.029. 2019 Jan;132(1):38-41. doi: 10.1016/j.amjmed.2018.06.028. Epub 2018 Jul 25.

Chen F, Zhang B, ParkerRB, Laizure SC. Clinical implications of genetic variation in carboxylesterase metabolism. Expert Opin Drug Metab Toxicol 2018; 14:131-142.

Chen F, Li DY, Zhang B, Sun JY, Sun F, Ji X, Qiu JC, Parker RB, Laizure SC, Xu J. Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: What is the potential clinical significance? Drug Metab Rev 2018:50:369-97.

Shell A, Sullivan J. Acute Kidney Injury Following Methimazole Initiation: A Case Report. Journal of Pharmacy Practice 2018. DOI 10.1177.

Wassell K, Sullivan J, Jett B, Zuber J. Comparison of Clinical Pharmacy Specialists and Primary Care Physicians in Treatment of Type 2 Diabetes Mellitus in Rural Veteran Affairs Facilities. Am J Health-Syst Pharm, Resident’s Edition; 2018: 75, Supplement 1; S6-S12. DOI 10.2146/ajhp160905

Keough, L.A., Krauss, A. & Hudson, J.Q. Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis. Int J Clin Pharm (2018) 40: 1250

Kessler SG, Gillion AR, Pattanaik D, Rogers KC. Nitrite allergy and desensitization in a patient with refractory angina. J Allergy Clin Immunol Pract 2018. pii: S2213-2198(18)30663-9. doi: 10.1016/j.jaip.2018.10.006.

Meduri GU, Siemieniuk RAC, Ness RA, Seyler SJ. Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS. J Intensive Care. 2018 Aug 24;6:53. doi:10.1186/s40560-018- 0321-9. PMID: 30155260.

Ness RA, Hoover JM. Amiodarone-induced interstitial lung disease diagnosed after discontinuation of amiodarone – A case report. CP Case. 2018 May 25;1:016.

Rogers KC, Finks SW. A new option for reversing the anticoagulant effect of factor Xa inhibitors: andexanet alfa (Andexxa®). Am J Med 2019;132(1):38-41. doi: 10.1016/j.amjmed.2018.06.028. Epub 2018 Jul 25.

Shell A, Rajanna K, Keough L. Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard- Versus Extended-Interval Zoledronic Acid. Federal Practitioner (2019).

McDonnell CC, Rogers KC, Regen SM, Finks SW. The fall risk with alpha blockers given initial dose or elderly staus (FRAGILE) study. Annal of Pharmacotherapy, 2019. DOI: 10.1177/1060028019880305

Laizure SC, ZY Hu, Potter PM, Parker RB. Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition. Xenobiotica 2019 DOI: 10.1080/00498254.2019.1612535

Laizure SC, Parker RB. Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine? Xenobiotica 2019 PMID: 31601149 DOI: 10.1080/00498254.2019.1678078

Layman SN, Guidry TJ, Gillion AR. Low-dose alteplase for the treatment of submassive pulmonary embolism: a case series. J of Pharm Prac, 2019. DOI: 10.1177/0897

Jacobs D, Wassel K, Guidry TJ, Sullivan J. Safety outcomes of atorvastatin 80 mg versus atorvastatin 40 mg in veteran population. Annals of Pharmacotherapy, 2019. DOI: 10.1177/1060028019877540

Ness RA, Bennett JG, Elliott WV, Gillion AR, Pattanaik DN. Impact of beta lactam allergies on antimicrobial selection in an outpatient setting. Allergy Asthma Proc. (submitted for publication)

Herndon K, Guidry TJ, Wassell K, Elliott W. Characterizing the safety profile of apixaban versus warfarin in moderate to severe chronic kidney disease at a veterans affairs hospital. Annals of Pharmacotherapy, 2019. DOI: 10.1177/1060002801987053

Mitchell AB, Ryan TE, Gillion AR, Wells LD, Muthiah MP.  Vitamin C and thiamine for sepsis and septic shock. Am J Med. May 2020

Rogers KC, Neu DW, Jaeger MC, Shah R, Finks SW. An Underappreciated and Prolonged Drug Interaction Leads to Ineffective Anticoagulation. South Med J. 2019;112(2):125‐129. doi:10.14423/SMJ.0000000000000926

Ness R, Gillion A, Elliott W, et al. “Impact of beta lactam allergies on antimicrobial selection in an outpatient setting. Southern Medical Journal. November 2019

Layman S, Elliott W, Regen S, Keough L. Implementation of a pharmacist-led transitional care clinic. Am J Health-Syst Pharm. 2020;77:966-971. DOI 10.1093/ajhp/zxaa080

Peters MJ, Marler JL, Kimmons LA, Ellingson S. Impact of fentanyl continuous infusion dosing strategies for analgosedation on medication usage. (Manuscript accepted to Hosp Pharm, pending publication).

Marler JL, Twilla JD, Finch CK, and Animalu C. Severe Ceftaroline-Induced Thrombocytopenia With Rapid Onset on Rechallenge. Ann Pharmacother. 2020 Feb;54(2):187-188.

Hamilton L, Suda K, Heidel R, McDonough S, Hunt M, Franks A.  The role of online learning in pharmacy education: A nationwide survey of student pharmacists.  Currents in Pharmacy Teaching and Learning, 2020.  DOI: 10.1016/j.cptl.2020.01.026

Hunt M, Yates J, Vega H, Heidel R, Buehler J.  Effects of postoperative gastrointestinal motility after neuromuscular blockade reversal with sugammadex versus neostigmine/glycopyrrolate in colorectal surgery patients.  Annals of Pharmacotherapy, 2020.  DOI: 10.1177/1060028020929061

Herndon K, Dewitt A, Gillion A, Pattanaik D. Infusion-related angioedema associated with infliximab-abda: Case report. Am J Health Syst Pharm. 2020 Oct 8:zxaa321. doi: 10.1093/ajhp/zxaa321. Epub ahead of print. PMID: 33031494.

Peters MJ, Ellingson SL, Kimmons LA, Marler JL. Impact of Fentanyl Continuous Infusion Dosing Strategies for Analgosedation on Medication Usage. Hosp Pharm. 2021 Oct;56(5):408-409. doi: 10.1177/0018578720925371. Epub 2020 May 22. PMID: 34720136.

McLean H, Wells L, Marler J. The effect of pre-arrest acid-base status on response to sodium bicarbonate and achievement of return of spontaneous circulation. Annals of Pharmacotherapy, 2021.  DOI

Mitchell A, Ness R, Bennett J, Bowden J, Elliott W, Gillion A, Pattanaik D. Implementation and Impact of a Beta-Lactam Allergy Assessment Protocol in a Veteran Population. Fed Pract. 2021 September;38(9):420-425.

Neu DW, Guidry TJ, Gillion AR, Pattanaik DN. Impact of Beta-lactam Allergies on Selection of Antimicrobials in an Inpatient Setting Among Veteran Population. Military Medicine, 2021 Mar. doi: 10.1093/milmed/usab004.

Madasu MK, Thang LV, Chilukuri P, Palanisamy S, Arackal JS, Sheahan TD, Foshage AM, Houghten RA, McLaughlin JP, McCall JG, Al-Hasani R. Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice. The Journal of Pain, 22(5), 582. May 2021.

Marler J, Howland R, Kimmons LA, Mohrien K, Vandigo JE, Jones GM. Safety of Propofol When Used for Rapid Sequence Intubation in Septic Patients: A Multicenter Cohort Study. Hosp Pharm. 2022 Apr;57(2):287-293. doi: 10.1177/00185787211029547. Epub 2021 Jul 8. PMID: 35601715.

Mclean H, Wells L, Marler J. The Effect of Prearrest Acid-Base Status on Response to Sodium Bicarbonate and Achievement of Return of Spontaneous Circulation. Ann Pharmacother. 2022 Apr;56(4):436-440. doi: 10.1177/10600280211038393. Epub 2021 Aug 5. PMID: 34353142

Rogers KC.  Stable Atherosclerotic Disease. In: Baker WL, Bolesta S, Coons J et al., eds. Cardiology Pharmacy Preparatory Review and Recertification Course, 2021 ed. Lenexa, KS: American College of Clinical Pharmacy, 2021:135-172.

Rogers KC, Chilbert MR. Stable Atherosclerotic Disease. In: Jackevicius C, Patterson JH, eds. Cardiology Self-Assessment Program, 2021 Book 1. Atherosclerotic Heart Disease. Lenexa, KS:  American College of Clinical Pharmacy, 2021:57-90.

Caviness, LA, Wassell KM, Howard-Thompson A, Acute elevation of liver function test values following concomitant administration of dabigatran and primidone. Am J Health Syst Pharm, Volume 79, Issue 15, 1 2022, Pages 1250–1254. https://doi.org/10.1093/ajhp/zxac

Ritter S, Bowden J, Pattanaik D. A case of perioperative anaphylaxis presenting as hereditary alpha trytasemia. Ann Alllergy Asthma Immunol 2022. https://doi.org/10.1016/j.anai.2022.03.011

Richmond C, Coveart S. Neutropenia and leukopenia after cross taper from quetiapine to divalproex for the treatment of borderline personality disorder. Fed Pract, 2022;36(4). doi:10.12788/fp.0247

Rogers KC, Spinler S.  Acute Coronary Syndromes.  In: Chisholm-Burns MA, Schwinghammer TL Malone PM, et al, eds.  Pharmacotherapy: Principles and Practice.  6th ed.  New York: McGraw-Hill Companies, 2022:157-184.

Finks SW. Rogers KC.  Ischemic Heart Disease and Acute Coronary Syndrome. In: Franks AS, Boucher BA, Borja-Hart N, Waddell JA, eds. Complete Review for Pharmacy, 13th edition. American Pharmacists Association. Washington, DC. 2022:293-326.

Rogers KC. Dual antiplatelet therapy duration after percutaneous coronary interventions.  Content Update 2021. In: Chisholm-Burns MA, Schwinghammer TL Malone PM, et al, eds.  Pharmacotherapy: Principles and Practice.  5th ed.  New York: McGraw-Hill Companies. Available at www.accesspharmacy.com

Swims, Melanie P. Arthritis. In: Franks AS, Boucher BA, Borja-Hart N, Waddell JA, eds. Complete Review for Pharmacy, 13th edition. American Pharmacists Association. Washington, DC. American Pharmacist 2022: https://doi.org/10.21019/9781582123615.ch26.

Gales K, Hunt M, Marler J. The association of elevated lactate with multiple vasopressor administration in patients with septic shock: a retrospective cohort study. Journal of Pharmacy Practice 2022: 1-8. DOI: 10.1177/08971900221128640

Givens G, Neu D, Marler J. The risk of major bleeding with apixaban administration in patients with acute kidney injury. Annals of Pharmacotherapy 2022:1-8. DOI: 10.1177/10600280221129831

National/Regional Presentations:

McGarry, M. Lipid Management: Beyond Statins. Presented at Mid-South College of Clinical Pharmacy November 12, 2020.

Cole S. Thrombotic Complications in COVID-19. Presented at Memphis Area Pharmacist Society November 10, 2020.

Neil, S. Train Wrecks in Transitions of Care: Improving the Process. Presented at APhA Annual Meeting 2019 PharmTalks Pharmacy Innovations Worth Spreading March 22-25, 2019, Seattle, WA

Ness, R. Presented at APhA Annual Meeting 2019 PharmTalks Pharmacy Innovations Worth Spreading March 22-25, 2019, Seattle, WA

Reducing Concomitant Utilization of Opioids and Benzodiazepines. Presented at 2018 VHA Shark Tank Live as part of the VHA Innovator’s Network. Shark Tank 2018 Finalist project – top 19 out of 622 practices submitted. Washington, D.C.

Sullivan J, Jett BP, Cradick M, Zuber J Effect of Clinical Pharmacist Intervention on A1C Reduction in Veteran Patients with Type 2 Diabetes in a Rural Setting. Presented by M Cradick at the Mid-South Residency Conference, Memphis, TN April 2015.

Wassell K, Sullivan J, Jett B, Zuber J. Hemoglobin A1C Reduction in Veteran Patients with Type 2 Diabetes Managed by Clinical Pharmacy Specialists Compared to Primary Care Physicians in a Rural Setting. Presented by K Wassell at the Mid-South Residency Conference, Memphis, TN April 2016.

Wassell K, Sullivan J, Jett B, Zuber J. Hemoglobin A1C Reduction in Veteran Patients with Type 2 Diabetes Managed by Clinical Pharmacy Specialists Compared to Nurse Practitioners in a Rural Setting.

Presented by K Wassell at the Mid-South Residency Conference, Memphis, TN April 2017.

Presented at 2017 National Pharmacy Resident Project Forum (RPro4)

VanBuskirk K, Elliott W, Sullivan J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic. Presented by K VanBuskirk at the Mid-South Residency Conference, Memphis, TN April 2017

Neil S, Keough L, Elliott W, Sullivan J, Zuber J. Outcomes of a Pharmacist-led Transitional Care and Polypharmacy Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017. Presented by S Neil at the Mid-South Residency Conference, Memphis, TN April 2017

Germinario V, Sullivan J, Elliott W, Zuber J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c reduction Compared to Primary Care Providers in an Outpatient Women’s. Presented by V Germinario at the Mid-South Residency Conference, Memphis, TN April 2018.

Shell, A., Keough, L.A., Rajanna, K.  Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard- Versus Extended-Interval Zoledronic Acid. Presented at Mid-South Pharmacy Residents Conference (MPRC). April 2018

Neil, S., Keough, L.A., Elliott, W., Outcomes of a Pharmacist-Led Transitional Care Clinic. Presented at Mid-South Pharmacy Residents Conference (MPRC). April 2018

Hoover J, Lavender D, Wells L. Risk of Venous Thromboembolism on Thrice Daily Subcutaneous Unfractionated Heparin in a Higher Versus Lower BMI Hospitalized Veteran Population. Poster presented at: Midsouth Residency Conference; 2018 April  19-20; Memphis, TN.

Hoover J, Lavender D, Wells L. Risk of Venous Thromboembolism on Thrice Daily Subcutaneous Unfractionated Heparin in a Higher Versus Lower BMI Hospitalized Veteran Population. Poster presented at: Midsouth Residency Conference; 2018 April  19-20; Memphis, TN.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Presented at The Mid-South Residency Conference. Memphis, TN. April 2017.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Selected for platform presentation at the Society of Critical Care Medicine Annual Congress. Honolulu, HI. January 2017.

Ness RA, Elliott WV, Gillion AR, Bennett JG, Pattanaik DN. Impact of beta lactam allergies on selection of antimicrobials in an outpatient setting. Presented at The Mid-South Residency Conference. Memphis, TN. April 2017.

Bland P, Gillion AR, Wells LD.  Fluid Balance as a Prognostic Marker of Mortality in Septic Shock. Presented at The Mid-South Residency Conference. Memphis, TN. April 2016.

Gordon S, Gillion AR, Wells LD. Beta Blockers for the Prevention of Post Cardiac Surgery Development of Atrial Fibrillation.  Presented at The Mid-South Residency Conference. Memphis, TN. April 2017.

Neu DW, Guidry TJ, Gillion AR, et al. Impact of Beta-lactam Allergies on Selection of Antimicrobials in an Inpatient Setting. Presented at the Mid-South Pharmacy Residency Conference. Memphis, TN. April 2018.

Ness RA. Selecting solutions that are worth their salt. ACPE accredited.  Memphis Area Pharmacists Society meeting. Oct 2018.

Hoover, Jonathan. Tips to Facilitate Precepting Success. Teaching and Learning Program for the UTHSC College of Pharmacy

Hoover, Jonathan. New England Journal Resident 360 Journal Club Faculty Panelist. Served as the faculty pharmacy panelist on an interactive, web based journal club which included University of Tennessee Health Science Center physician faculty and residents, along with the authors of the “Partial Oral Treatment of Endocarditis (POET)” trial.  

Hoover, Jonathan. IPECS Course at University of Tennessee College of Pharmacy. Diabetic case overview.

Hoover, Jonathan. Rho Chi Residency Workshop. University of Tennessee College of Pharmacy. Discussed interviewing tips and tricks for interested Rho Chi P3 and P4 students (30-40 students).  Also incorporated mock interview process

Hoover, Jonathan. Community-Acquired Pneumonia Review. 30 minute presentation presented at morning report for interns, residents, and attending physicians from the Veterans Affairs Medical Center 

Hoover, Jonathan. Providing Effective Feedback and Documentation. Veterans Affairs Tennessee Valley Healthcare System as part of Preceptor Development Seminar.  Regional conference in Nashville, TN and was available as 1 hour CE for pharmacists 

Hoover, Jonathan. Providing Guidance Through Feedback and Evaluations. 1 hour presentation given for Pharmacotherapy Rounds to pharmacists and pharmacy residents at the Memphis Veterans Affairs Medical Center 

Hoover, Jonathan. Reality APPE: Real Life Experiences with Real Life Preceptors. University of Tennessee Health Science Center College of Pharmacy Preceptor Development Conference.  Regional conference in Memphis, TN and was available as 1 hour CE 

Hoover, Jonathan. Best Practices in Precepting Students and Standing Out on Rotation. Tennessee Pharmacist Association Emerging Leaders Program.  Regional meeting in Memphis, TN and was available as 1 hour CE for pharmacists. 

Hoover, Jonathan. Medication Based Therapy in Heart Failure. Presented for approximately 75 physicians for the Office of Graduate Medical Education for the University of Tennessee, Memphis  

Hoover, Jonathan. Hypertension Medications in CKD. Morning report for interns, residents, and attending physicians from the Veterans Affairs Medical Center 

Hoover, Jonathan. Antihypertensive Medication Considerations in Chronic Kidney Disease. University of Tennessee College of Medicine.

Swims, Melanie. RA, OA and Pharmacology of NSAIDs, University of Tennessee, 2018.

Swims, Melanie. DMARDS, University of Tennessee, 2018,

Swims, Melanie . Treatment of Psoriatic Arthritis and Immunosuppressants in Rheumatology, University of Tennessee, Rheumatology Conference, October 2018.

Swims, Melanie. Biologic DMARDS. University of Tennessee, Rheumatology Conference, October 2018.

Swims, Melanie. Traditional DMARDS, University of Tennessee, Rheumatology Conference, September 2018.

Swims, Melanie. NSAIDS, University of Tennessee, Rheumatology Conference, September 2018.

Swims, Melanie. Rheumatology Update, VAMC. Pharmacotherapy Rounds, July 2018.

Swims, Melanie. Rheumatology Pharmacotherapy: Pitfalls and Pearls. University of Tennessee, College of Medicine Noon Conference, May 2018. 

Rainey, Carly. VISN 10 Pharmacy Presentation over Conversion Disorder, September 2021. ACPE credit possible

Gillion, Amanda. ABLE Initiative. Presented at Specialty Care ICC National Committee Presentation. Virtual "Are you Ready and ABLE (allergy to beta lactam evaluation) CPPO podcast.

Gillion, Amanda. Virtual Allergy to Beta Lactam Evaluation - ABLE Project Presentation. Presented at VISN Pharmacy Executive (VPE) National CPPO meeting.

Gillion, Amanda. Virtual Beta Lactam Allergy Assessments (BLAA) and CPPO Task Force. Presented at National Antimicrobial Stewardship Task Force (ASTF) webinar (CE accredited). Virtual

Rogers, Kelly. Heart failure Update, 2021 Fall Therapeutics Seminar. Memphis, TN. November13, 2021.  ACPE UAN: 0064-0000-21-055-L01-P&T

Rogers, Kelly. Stable Atherosclerotic Disease”, 2021 ACCP/ASHP Cardiology Preparatory Review and Recertification Online Course. March 2021; 1.5 contact hours.

Sullivan Joshua and Ponnapula, Supriya. Monitoring and Evaluating Efficiency and Productivity Presented at national CPPO PACT/CPL Bootcamp. April 2022. CE accredited.

Posters:

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Presented at the American College of Clinical Pharmacy Annual Meeting. Hollywood, FL. October 2016

Rogers KC, Elliott NT, Greiner LE, Majaj N, Brenner M, Finks SW.  Appropriate monitoring to improve sotalol safety.   Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. 2016-Hollywood, FL.  Abstract #200

Farrar J, Chen F, Parker RB, Laizure SC. Effects of commonly prescribed drugs on dabigatran etexilate hydrolysis by carboxylesterases. Presented at the ACCP Annual Meeting, Phoenix, AZ, October 2017.

Shahreyar M, Morsy M, Heckle M, Rashid A, Ramanathan K, Rogers KC, Shah R.  An updated comprehensive meta-analysis of randomized trials evaluating the efficacy of stem cell therapy for refractory angina. American College of Cardiology 2017. Washington, D.C.; Presentation Number: 1178M-03. 

Morsy M, Heckle M, Shahreyar, Delgado G, Ramanathan K, Rogers KC, Shah R.  Shorter- versus longer-duration triple antithrombotic therapy for patients with coronary stents who require oral anticoagulation: an updated comprehensive meta-analysis. American College of Cardiology 2017.  Washington, D.C.; Presentation Number: 17-A-10191-ACC.

Atyia S, Rogers KC, Finks SW.  Effects of carvedilol prescribed at discharge in patients with cocaine-induced chest pain.  Program and Abstracts of the 52nd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 4, 2017 – Orlando, FL; Abstract # 2-336.

Jaeger M, Finks SW, Neu D, Rogers KC.  Transitions of care nightmare:  Induction of an enzyme leads to a reduction in anticoagulant efficacy.  Program and Abstracts of the 52nd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 4, 2017 – Orlando, FL; Abstract # 2-340.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Presented at the American College of Clinical Pharmacy Annual Meeting. Hollywood, FL. October 2016.

Neil S, Keough L, Elliott W, Sullivan J, Zuber J. Outcomes of a Pharmacist-led Transitional Care and Polypharmacy Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017. Presented by S Neil at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Selected for platform presentation at the Society of Critical Care Medicine Annual Congress. Honolulu, HI. January 2017.

Kessler, S, Sullivan J, Zuber J. Comparison of Diabetes Outcome Disparities Between Men and Women.

Presented at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

Germinario V, Elliott W, Sullivan J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic. Co-Principal Investigator. Presented by V Germinario at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

VanBuskirk K, Elliott W, Sullivan J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017.

Presented by V Germinario at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

Neil S, Keough L, Elliott W, Sullivan J, Zuber J. Outcomes of a Pharmacist-led Transitional Care and Polypharmacy Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017. Presented by S Neil at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017.

Kessler, S, Sullivan J, Zuber J. Comparison of Diabetes Outcome Disparities Between Men and Women.

Presented at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

Neu DW, Guidry TJ, Gillion AR, et al. Impact of Beta-lactam Allergies on Selection of Antimicrobials in an Inpatient Setting. Presented at the American College of Clinical Pharmacy Annual Meeting. Phoenix, AZ. October 2017.

Ness RA, Elliott WV, Gillion AR, Bennett JG, Pattanaik DN. Impact of beta lactam allergies on selection of antimicrobials in an outpatient setting. ACCP 2017. Poster #402.

Sullivan J, Berntson G, Freeman K, Patton J, Keough LA, Morton T. Reducing Concomitant Utilization of Opioids and Benzodiazepines. Presented at VHA Innovation Experience Demo Day, Washington, D.C. August 2018.

Rogers KC, Gabre E, Elliott N, Garner K, Finks SW.  VAMP-IT:  Veteran antiarrhythmic monitoring program-improving therapy. ACCP Updates in Therapeutics® 2018 – Jacksonville, Florida.  Abstract # F-19.

Jacobs D, Wassell K, Guidry T, Sullivan J. Safety and cardiovascular outcomes of high-intensity statin therapy with atorvastatin 80mg versus atorvastatin 40mg in the veteran population. Presented at the American College of Pharmacy Annual Meeting. Seattle, WA. October 2018.

Kessler SG, Gillion AR, Rogers KC, Pattanaik D.  Nitroglycerin desensitization protocol in nitroglycerin-induced urticaria.  Tennessee Society of Health System Pharmacists (TSHP) Midyear Meeting.  2018 - Nashville, TN.

Shah R, Nayyar M, Bondy BR, Chaudhry A, Butt AK, Shell A, Rogers KC. Effect of pre-procedural heparin administration on bivalirudin-based anticoagulation strategy during primary percutaneous coronary intervention: a network meta-analysis. American College of Cardiology March 12, 2018.  Orlando, FL. Presentation Number: 1287-261.

McDonnell CC, Rogers KC, Regen SM, Finks SW.  PRescribing Alpha blockers Including praZosin in the Elderly: the PRAIZE safety study. Program and Abstracts of the 53rd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 2, 2018 – Anaheim, CA.  Abstract # 1-349

Childress MB, Rogers KC, Finks SW. Ranolazine in refractory angina in a patient with end stage renal disease.  Program and Abstracts of the 53rd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 2, 2018 – Anaheim, CA.  Abstract # 3-387

Boh, J., Coveart S., Keough LA., Patton J. Outcomes of an Opioid-Benzodiazepine Co-Prescribing Reduction Plan.  Presented at America Society of Health Systems Pharmacists (ASHP). December 2018

Shell, A., Keough, L.A., Rajanna, K.  Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard- Versus Extended-Interval Zoledronic Acid. Presented at Association of VA Hematology/Oncology (AVAHO). September 2018

Ye, S, Wells, LD. Gillion, AR. “Assessment of Pre-Admission Use of Calcium Channel Blockers Versus Beta Blockers in Patients Admitted with Sepsis” ACCP Global Meeting; Seattle, WA

Ye, SY. Dembski, VR. “Evaluation of a Pharmacy Student-Driven Medication Review on 30-Day Readmission Rates in a 49-Bed, Rural Community Hospital” ASHP Midyear Clinical Meeting; Orlando, FL

Clarkson M, Hoover J, Wells L. Rates of Venous Thromboembolism in Hospitalized Patients Receiving Unfractionated Heparin Thrice Daily in Higher Versus Lower BMI Patients. Poster presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; 2018 Oct 20-23; Seattle, WA.

Kessler, SG, Coveart S. Evaluation of Benzodiazepines Use in Patients with Post-Traumatic Stress Disorder. Presented by S. Kessler at the American College of Clinical Pharmacy Annual Meeting, Seattle, WA October 2018.

Ye S, Wells L, Gillion A. Assessment of Pre-Admission Use of Calcium Channel Blockers Versus Beta Blockers in Patients Admitted with Sepsis. Poster presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; 2018 Oct 20-23; Seattle, WA.

Clarkson M, Hoover J, Wells L. Rates of Venous Thromboembolism in Hospitalized Patients Receiving Unfractionated Heparin Thrice Daily in Higher Versus Lower BMI Patients. Poster presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; 2018 Oct 20-23; Seattle, WA.

Ye S, Gillion AR, Well LD.  Assessment of Pre-Admission Use of Calcium Channel Blockers Versus Beta Blockers in Patients Admitted with Sepsis. Presented at the American College of Clinical Pharmacy Global Meeting. Seattle, WA. October 2018.

Herndon K, Guidry T, Wassell K, Elliott W. Safety Profile of Apixaban versus Warfarin in Veterans with Chronic Kidney Disease. Presented at the American College of Pharmacy Annual Meeting. Seattle, WA. October 2018.

Gillion A, Elliott W. Saving Lives One Assessment at a Time: Beta Lactam Allergy Assessments. Selected to be presented at VHA Innovation Demo Day. Washington DC. October 2019 (Also selected as VHA 2019 Shark Tank Semi-finalist).

Roberts AM, Rogers KC, Finks SW.  Ranolazine use in patients with chronic kidney disease +/- renal replacement therapy.  American College Clinical Pharmacy 2019 Virtual Poster Symposium, May 28, 2019.  Abstract #49256

Laizure S, He H, Parker RB. Alcohol consumption likely to increase clopidogrel antiplatelet activity. Presented at the ACCP Global Conference on Clinical Pharmacy, Seattle, WA, October 2018.

Herndon K, Dewitt A, Gillion AR. Hypersensitive reaction to infliximab-abda(biosimilar to infliximab): A Case report. Presented by K. Herndon at the (ACCP) Conference. New York, NY. October 2019.

McGlaughlin BT, Clarkson MK, Wassell KM, Finks SW, Rogers KC.  Safety and efficacy of direct-acting oral anticoagulants (DOACs) in the obese population. American College of Clinical Pharmacy Annual Meeting. October 28, 2019 - New York City, NY.  Abstract #51933

Mitchell AB, Guidry TJ, Gillion AR. Micafungin Resistance to Candida albicans in a Non-immunocompromised Host: A Case Report. Presented by A. Mitchell at the (ACCP) Conference. New York, NY. October 2019.

Lenahan SM, Guidry TJ, Bowden JE, Gillion AR. Evaluation of Outcomes in Invasive Candidiasis Treated with Micafungin in Obese versus Non-obese Patients. Presented at the American College of Pharmacy Annual Meeting. New York City, NY. October 2019.

Mitchell AB, Ryan TE, Gillion AR, Wells LD, Muthiah MP.  Vitamin C and thiamine for sepsis and septic shock. Presented by A. Mitchell at Society of Critical Care Medicine. San Diego, CA. February 2019.

Howard TG, Hamby A, Layman SN, Neu DW, Elliott WV. Alogliptin and heart failure outcomes in patients with type II diabetes. Poster presentation presented at the American College of Clinical Pharmacy Annual Meeting. New York, NY. October 2019.

Clarkson M, Hoover J, Elliott W, Eason J. High-dose daptomycin in ESRD as a part of triple antibiotic therapy in a patient with persistent MRSA bacteremia: case report. Presented at ACCP Annual Meeting, New York, NY. October 2019.

Howard G, Hamby A, Elliott W. Alogilptin and Heart Failure Outcomes in Patients with Type II Diabetes. Principle Investigator. Presented at the ACCP Annual Meeting. New York, NY. October 2019

Laizure SC, Parker RB. Does clopidogrel decrease the efficacy of carboxylesterase-1 prodrugs? Selected for presentation at the 2020 American Society of Pharmacology and Experimental Therapeutics Annual Meeting.

Mclean H, Wells L, Marler JL. The Effect of Sodium Bicarbonate on Return of Spontaneous Circulation in Patients with Cardiac Arrest. Virtual Presentation at ACCP Virtual Poster Symposium. May 26-27, 2020.

Keen W, Elliott W, Layman S, Sullivan J. Intravenous Iron Replacement in Hospitalized Heart Failure Patients. Presented at 2020 ACCP Virtual Symposium, May 2020.

Sela Cathright, Sloan Regen, Shannon Stewart. Assessment of adverse effects of zolpidem, zaleplon, eszopiclone in a Veteran population. Presented at 2020 CPNP Virtual Annual Meeting.

Phomakay V, Layman S, Swims M, Bennett J, Gupta S. Improvement in pneumococcal and herpes zoster vaccination rates of persons with chronic inflammatory disease on biologic immunosuppressive medications: A quality improvement project. Presented at UT Research Day, Memphis, TN January 2020.

Hunt M, Frisbee J, Winters S, Dudney T, Heidel R, Branca P.  Hydrocortisone and fludrocortisone versus hydrocortisone alone in critically ill patients with septic shock.  Platform presentation at Society of Critical Care Medicine Critical Care Congress.  Orlando, FL. February 2020.

Clarkson M, McGlaughlin B, Wassell K, Finks S, Rogers K. Safety and efficacy of direct-acatin oral anticoagulants (DOACs) in the obese population. Presented at 2020 ACC Virtual Meeting, March 2020.

McGarry M, Keough L, Wassell K. Assessment of renal outcomes with empagliflozin use in a veteran population with type 2 diabetes and proteinuria. Presented at 2020 ACCP Virtual Meeting, May 2020.

Slayton, M, Lerma J, Latendresse E, Ponnapula S. Comparing HbA1c lowering of SGLT2 inhibitors and GLP-1 agonist. Presented at TPA Winter Virtual Meeting, February 2020.

Hollums B, Ryan T, Wells L, VanBuskirk K. Comparison of direct oral anticoagulants and warfarin in patients with advanced liver disease. Presented at 2020 ACCP Virtual Symposium, May 2020.

Cole B, Brandl E, Keller A. Comparison of combined therapy with metronidazole versus piperacillin/tazobactam on postoperative infectious outcomes in acute cholecystitis patients undergoing cholecystectomy in a veteran population. Presented at 2020 ASHP Virtual Symposium, December 2020.

Gales K, Hunt M, Marler J. The effect of lactic acidosis on norepinephrine efficacy and the need for vasopressin therapy in patients with septic shock. Presented at 2021 ACCP Virtual Symposium, May 2021.

Lerma J, Guidry TJ, May S. Outcomes of a Pharmacist-Led Telehealth Clinic for Spinal Cord Injury Patients. Presented at 2020 ASHP Virtual Symposium, December 2020.

Thel M, Marler J, Ryan T. Effect of fluid resuscitation volume on outcomes in septic patients with heart failure. Presented at 2021 ASHP Virtual Symposium, December 2020.

Fong R, Bennett J, Bowden J. Impact of Pharmacist-driven Stewardship Efforts in the Emergency Department and Outpatients Clinics. Presented at 2020 ASHP Virtual Symposium, December 2020.

Cole S, Wells L, Gillion A. Steroids in Non-Critically Ill Hospitalized Patients with COVID-19 Requiring Supplemental Oxygen. Presented at 2020 ASHP Virtual Symposium, December 2020.

Butterfass C, Hunt M, Wells L. The effect of hyperglycemia on outcomes in hospitalized COVID-19 patients without diabetes receiving corticosteroids. Presented at 2021 ASHP Virtual Symposium, December 2021.

Caviness L, Sullivan J, Ponnapula S, Townsend N. Efficacy and Tolerability of a Formulary Conversion from Dulaglutide to Semaglutide in a Veteran Population. Presented at 2021 ASHP Virtual Symposium, December 2021.

Elliott J, Layman S, Regen S. Evaluation of the implementation of a pharmacist-led transitions of care discharge process in high-risk Veteran patients. Presented at 2021 ASHP Virtual Symposium, December 2021.

Gillis C, Stewart S, Guidry TJ, May S. Topical Diclofenac and Risk of Adverse Events. Presented at 2021 ASHP Virtual Symposium, December 2021.

Givens G, Neu D, Marler J. Does continuing apixaban in patients with acute kidney injury increase risk of major bleeding? Presented at 2021 ASHP Virtual Symposium, December 2021.

Morgan J, Wells L, Goggans M, Hunt M. Assessment of Outcomes in Hospitalized COVID-19 Patients Receiving Steroid Therapy with Well Controlled Versus Poorly Controlled Preexisting Diabetes. Presented at 2021 ASHP Virtual Symposium, December 2021.

Ponder A, Ryan T, Hoover J. Prescribing Patterns and Incidence of Gout Flares in a Veteran Population. Presented at 2021 ASHP Virtual Symposium, December 2021.

Thel M, Latendresse, Gillion A, Peyton L. Safety of Direct Acting Oral Anticoagulants in Patients with Active Gastrointestinal Cancer. Presented at 2021 ASHP Virtual Symposium, December 2021.

Wuerger A, Bowden J, Mitchell A, Marler J. Effect of Vancomycin Plus Piperacillin-tazobactam on the Incidence of Acute Kidney Injury in Obesity. Presented at 2021 ASHP Virtual Symposium, December 2021.

Butler BM, Parker RP, Rogers KC. Pharmacist-led initiative to increase guideline-directed management and therapies in veterans with PAD. American College of Clinical Pharmacy Annual Meeting Virtual Poster Session. October 2021.

Smith SE, Rogers KC, Newsome AS, Fulford M. Long-term retention of advanced cardiac life support (ACLS) knowledge after American Heart Association ACLS certification. American Association of Colleges of Pharmacy Virtual Pharmacy Education Annual Meeting. July 12-22, 2021.

Butler BM, Parker RP, Rogers KC. Pharmacist-led initiative to increase guideline-directed management and therapies in veterans with PAD. American College of Cardiology Cardiovascular Pharmacists Poster/Platform Virtual Poster Symposium, April 7, 2022.  

Butler BM, Parker RP, Rogers KC. Pharmacist-led initiative to increase guideline-directed management and therapies in veterans with PAD.  Tennessee Society of Hospital Pharmacist’s Winter Meeting.  February 2022 - Nashville, TN.  Student Posters Session

Analysis and Follow-Up of a Long-Acting Injectable Standard Operating Procedure Implementation at a Veterans Affairs Medical Center. Presented at CPNP Annual, April 2022.

Strength R, Patel J, Eason J, Bennett J, Bowden, J, Thomas-Gosain N. Biofiring on All Cylinders: Determining Optimal Utility of the BioFire Pneumonia Panel. The University of Tennessee Health Science Center and Memphis VA Medical Center. Poster presented at ID Week Annual Meeting 2021.

Byrd J, Bennett J, Bowden J, Eason J, Thomas-Gosain, N. Impact of COVID-19 on Inpatient Antibiotic Utilization Trends. The University of Tennessee Health Science Center and Memphis VA Medical Center. Poster presented at ID Week Annual Meeting 2021. 

 

Awards:

Outstanding Youth Alumnus for the Year, 2015, Jonathan Hoover

Preceptor of the Year, Union University, 2015, Jonathan Hoover

Student Government Association Executive Council Excellence in Teaching Award UTHSC, 2016, Jonathan Hoover

Preceptor of the Year, April 2018, Jonathan Hoover

Tennessee Society of Health-System Pharmacists Pharmacist of the Year, July 2018, Joshua Sullivan

American College of Clinical Pharmacy Ambulatory Care PRN Resident Travel Award – Sara Neil

American College of Clinical Pharmacy Ambulatory Care PRN Resident Travel Award  – Tommie Jo Guidry

Undersecretary of Health Excellence in Pharmacy Practice Award, 2018.

Tennessee Society of Health-Systems Pharmacists Residency of the Year award, 2019

Tennessee Pharmacist Association Excellence in Innovation Award, Amanda Gillion, July 2020.

 

List of Resident Projects Completed in last 5 years:

Digoxin Use in Veterans with Heart Failure in Normal Sinus Rhythm or Atrial Fibrillation

Appropriate Monitoring to Improve Sotalol Safety and Tolerability

Determining the Effects of a Hepatitis C Healthcare Provider Team on Sustained Virologic Response Rates in a Veteran Population

Fluid resuscitation in septic shock:  Fluid balance as a prognostic factor

Outcomes of a Pharmacist Led Hospital Discharge and Polypharmacy Clinic

Mortality Risk Associated with Methicillin-resistant and Methicillin-sensitive Staphylococcus aureus Bacteremia

Evaluation of Prolonged Antibiotic Therapy for Clostridium Difficile Due to Repeat Toxin PCR Testing

Antimicrobial Utilization Benchmarking

Effect of Clinical Pharmacist Intervention on A1c Reduction in Patients with Type II Diabetes in a Rural Setting

Clinical outcomes in veteran patients with Staphylococcus aureus bacteremia

Retrospective Chart Review of Spinal Cord Injury (SCI) Patients with Asymptomatic Bacteriuria Undergoing Traumatic Genitourinary Procedures: An Effort to Determine Appropriate Antimicrobial Prophylactic Duration

Prediction of Invasive Candidiasis in a Veteran Population (PIVET):Validation of the Candida Score

Beta Blockers for the Prevention of Post Cardiac Surgery Development of Atrial Fibrillation

Impact of Long Term Opioid Therapy on Functional Status Among Chronic Pain Patients

Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic

Effect of Clinical Pharmacist on A1C reduction in an Outpatient Rural Setting Compared to Traditional Management by a Primary Care Provider.  

Implementation of a Medicine Discharge Clinic and Outcomes

Appropriate Monitoring to Improve Amiodarone Safety and Tolerability

The Effects of Albiglutide in Addition to Basal/Bolus Insulin Therapy in Veterans with Uncontrolled Type II Diabetes Mellitus

Comparison of Hemoglobin A1c Reduction in Veteran Patients with Type II Diabetes Managed by Clinical Pharmacists Compared to Nurse Practitioners in a Rural Setting

Comparison of Hemoglobin A1c Reduction in Patients with Type II Diabetes Managed by Clinical Pharmacists versus Primary Care Providers

VAMP-IT: Veteran Antiarrhythmic Monitoring Program-Improving Therapy

Rates of Venous Thromboembolism in Hospitalized Patients Receiving Unfractionated Heparin Thrice Daily in Higher Versus Lower BMI Patients

Outcomes of a Pharmacist-Led Transitional Care Clinic (TCC)

Assessment of Diabetes Outcome Disparities Between Male and Female Veterans Effect of Clinical Pharmacists on Hemoglobin A1c Reduction in an Outpatient Ambulatory Care Women’s Clinic

Risk of Venous Thromboembolism on Thrice Daily Subcutaneous Unfractionated Heparin in a Higher Versus Lower BMI Hospitalized Veteran Population

Evaluation of Proton Pump Inhibitors’ Association with QT Prolongation

Impact of beta lactam allergies on antimicrobial selection in an outpatient setting

Impact of beta lactam allergies on antimicrobial selection in an inpatient setting

Evaluation of Bisphosphonate Use in Multiple Myeloma Patients

Safety profile of apixaban versus warfarin in Veterans with chronic kidney disease

Evaluation of Opioid Use Reduction in Patients with High Morphine Equivalent Daily Doses (MEDD)

Assessment of pre-admission use of calcium channel blockers versus beta blockers in patients admitted with sepsis

Vitamin C, Thiamine and Hydrocortisone in the Treatment of Veteran Patients with a Primary Diagnosis of Septic Shock

Clinical impact and cost analysis of a beta lactam allergy assessment protocol in a Veteran population

PRescribing Alpha blockers Including praZosin in the Elderly: the PRAIZE safety study

Safety outcomes of atorvastatin 80mg versus atorvastatin 40mg in a veteran population

Reduction of Opioid and Benzodiazepine Combination Program Outcomes

Safety comparison of factor Xa inhibitors and warfarin in patient with cirrhosis

Assessment of adverse effects of zolpidem, zaleplon, eszopiclone in a veteran population

Efficacy comparison of SGLT2 inhibitors and GLP1 agonists in patients with poorly controlled diabetes

The role of sodium bicarbonate in cardiac arrest patients

Assessment of Renal Outcomes with Empagliflozin Use in a Veteran Population with Type 2 Diabetes

Effects of Intravenous Iron in Patients with Heart Failure

Assessment of Heart Failure Outcomes in Patients on DPP4 Inhibitors Alogliptin and Saxagliptin

Treatment of Candidemia with Micafungin in Higher Versus Lower BMI patients

Safety and efficacy of DOACs in the obese population

Impact of Beta Lactam Allergy Assessment Protocol in a Veteran Population

Incidence of gout flare upon initiation of urate lowering therapy with and without anti-inflammatory prophylaxis

Assessment of outcomes in hospitalized COVID19 patients receiving steroid therapy with well controlled versus poorly controlled preexisting diabetes

The effect of hyperglycemia on outcomes in hospitalized COVID19 patients without diabetes receiving corticosteroids

Does continuing apixaban in patients with AKI increase bleed risk?

Does zosyn increase rates of AKI in septic patients who are obese?

Safety of DOACs in patients with active GI cancer

A1c Reduction in a Veteran Population On Semaglutide versus Dulaglutide  

Evaluation of the implementation of a pharmacist-led transitions of care discharge process in high risk Veteran patients

Topical Diclofenac and Risk of Adverse Events 

Assessment of outcomes in hospitalized COVID19 patients receiving steroid therapy with well controlled versus poorly controlled preexisting diabetes

The effect of hyperglycemia on outcomes in hospitalized COVID19 patients without diabetes receiving corticosteroids

Optimal vancomycin weight-based dosing to achieve AUC 400-600 stratified by BMI

Impact of stewardship intervention on antibiotic prescribing prior to dental procedures in patients with joint replacement

Significance of the Loading Phase Duration of Apixaban for VTE or PE After Initial Anticoagulation Treatment with  Heparin or Lovenox

Pharmacist-Led Initiative to Increase Guideline-Directed Therapies in Veterans with PAD

Risk of Acute Kidney Injury after Addition of Empagliflozin to Background Congestive Heart Failure Therapy in a Veteran Population

Entresto Utilization and Impact on Heart Failure Readmissions in African American or Patients with Obesity

Pharmacist-Led Initiative to Improve Diabetes Management in Patients with Cardiovascular Disease

 

List of Resident Medication Use Evaluations Completed in last five years:

Erythropoietin Use

Colchicine Prescribing at VAMC

Evaluation of Metoclopramide Use

Dronedarone in Patients with Heart Failure

Incidence of Thrombosis with use of Megestrol

Pneumococcal Vaccines

Opioid-Induced Hypogonadism

Time to First Dose (“NOW”) Antibiotics

Evaluation of Niacin Use

Monitoring Frequency for Spironolactone and Eplerenone

Metformin Prescriptions in Patients with Serum Creatinine Greater than 1.5

Memantine in Patients with Alzheimer’s Disease

Testosterone Use in a Veteran Population

Nitrofurantoin Use in a Veteran Population

Effect of Oral Non-steroidal Anti-inflammatory Drugs (NSAID) in Combination with Topical Diclofenac Gel

Vancomycin Dosing - Without Levels, Without Documentation

Tolerance of Beta-Lactam Antibiotics After Entry of Beta-Lactam Allergy

Evaluation of Metoclopramide Use

Effect on INR Control with Conversion to New Generic Warfarin Formulation

Time to Administration of Now Doses of Vancomycin and Piperacillin-Tazobactam among Inpatients at the Memphis VAMC

Prescribing of Immediate Acting Antiepileptic Drugs

Drug Use Evaluation of Triple Antithrombotic Therapy

Evaluating First Dose (“NOW”) of Vancomycin and Zosyn

Time to First Dose (“NOW”) Antibiotics

Evaluation of Outcomes in Patients with Heart Failure who are Prescribed NSAIDs

Lithium Monitoring and Safety

Amikacin Monitoring and Safety

Electrocardiogram Monitoring in the Setting of Methadone Treatment

Monitoring of Direct Oral Anticoagulants

Increased Eylea Use in the Ophthalmology Clinic

Albiglutide in Patients with Diabetes Mellitus

Direct Oral Anticoagulants and Liver Injury

Benzodiazepine Utilization in Patients with Post-Traumatic Stress Disorder

Veteran’s Transitioned from Three Times Daily to Twice Daily Pregabalin Dosing

Glucocorticoid Induced Osteoporosis

Lithium in Patients with Psychiatric Disorders

Prescribing Trends of Antibiotics for Prophylaxis Around Prostate Biopsy Performed at the Memphis Veterans Affairs Medical Center

Pneumococcal Vaccination in Rheumatoid Arthritis Patients

Cost-Effectiveness of SGLT2 inhibitors and GLP1 receptor agonists

Febuxostat and Risk of Cardiovascular Events

Concomitant Use of IM Olanzapine and Benzodiazepines

Daptomycin CFU Evaluation

Treatment of Asymptomatic Bacteriuria

Vancomycin Removal via Hemodialysis Filtration

Appropriate Dosing of Simvastatin when used with Interacting Drugs

Assessment of SSRI and SNRI Combination Therapy

Concomitant Use of IM Olanazapine and Benzodiazepines

Daptomycin Criteria for Use

Peri-procedural antibiotic use in patients with listed beta lactam allergies

Benzodiazepine use in patients with Post Traumatic Stress Disorder

Appropriate Dose Transition of Ticagrelor After 1 Year Post-Acute Coronary Event

Criteria for Use and Rate of Hospitalization with Sacubitril/Valsartan (Entresto)

Evaluation of ADRs and Mortality Among Remdesivir Patients to Date

Drug Use Evaluation Metformin Dosing with Concurrent Ranolazine

Correlation of Initial Procalcitonin and Culture Results in Patients with Infection

Accuracy of the biofire BCID2 panel for both organisms and resistance genes through correlation with blood cultures

Correlation of Initial Procalcitonin and Culture Results in Patients with COVID-19

Use of Antibiotics in Patients with COVID-19

Failure of Wixela® in patients with COPD

Quetiapine Prescribing Practices and PADR Requirements

More About Memphis

You can learn more about the Memphis, Tennessee area by browsing to the links below. But remember, these links will take you outside the Department of Veterans Affairs Website and VA does not endorse and is not responsible for the content on these sites.

Contact Information

For more information about the PGY1 or PGY2 Ambulatory Care Residency Program, please contact:

Joshua Sullivan, PharmD, BCACP, BCPS, BCGP
Associate Chief, Clinical Pharmacy Programs
PGY1 Pharmacy Residency Program Director
PGY2 Ambulatory Care Residency Program Director
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN
Phone: 901-577-7100
Email: josh.sullivan@va.gov

For more information about the PGY2 Internal Medicine Residency Program, please contact:

Tenley E. Ryan, PharmD, BCPS
Clinical Pharmacy Specialist – Internal Medicine/Transitions of Care
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN
Phone: 901-523-8990 x6720
Email: tenley.ryan@va.gov